NF-kappaB_NN
functions_VBZ
as_IN
both_CC
a_DT
proapoptotic_JJ
and_CC
antiapoptotic_JJ
regulatory_JJ
factor_NN
within_IN
a_DT
single_JJ
cell_NN
type_NN
._.

Recently_RB
NF-kappaB_NN
has_VBZ
been_VBN
shown_VBN
to_TO
have_VB
both_CC
proapoptotic_JJ
and_CC
antiapoptotic_JJ
functions_NNS
._.

In_IN
T_NN
cell_NN
hybridomas_NNS
,_,
both_CC
T_NN
cell_NN
activators_NNS
and_CC
glucocorticoids_NNS
induce_VBP
apoptosis_NN
._.

Here_RB
we_PRP
show_VBP
that_IN
blockade_NN
of_IN
NF-kappaB_NN
activity_NN
,_,
using_VBG
a_DT
dominant_JJ
negative_JJ
IkappaBalpha_NN
,_,
has_VBZ
opposite_JJ
effects_NNS
on_IN
these_DT
two_CD
apoptotic_JJ
signals_NNS
._.

Treatment_NN
with_IN
PMA_NN
plus_CC
ionomycin_NN
-LRB-_-LRB-
P\/I_NN
-RRB-_-RRB-
results_VBZ
in_IN
the_DT
upregulation_NN
of_IN
Fas_NN
Ligand_NN
-LRB-_-LRB-
FasL_NN
-RRB-_-RRB-
and_CC
induction_NN
of_IN
apoptosis_NN
._.

Inhibition_NN
of_IN
NF-kappaB_NN
activity_NN
inhibits_VBZ
the_DT
P\/I_NN
mediated_JJ
induction_NN
of_IN
FasL_NN
mRNA_NN
and_CC
decreases_VBZ
the_DT
level_NN
of_IN
apoptosis_NN
in_IN
these_DT
cultures_NNS
,_,
thus_RB
establishing_VBG
NF-kappaB_NN
as_IN
a_DT
proapoptotic_JJ
factor_NN
in_IN
this_DT
context_NN
._.

Conversely_RB
,_,
inhibition_NN
of_IN
NF-kappaB_NN
confers_VBZ
a_DT
tenfold_JJ
increase_NN
in_IN
glucocorticoid_NN
mediated_JJ
apoptosis_NN
,_,
establishing_VBG
that_IN
NF-kappaB_NN
also_RB
functions_VBZ
as_IN
an_DT
antiapoptotic_JJ
factor_NN
._.

We_PRP
conclude_VBP
that_IN
NF-kappaB_NN
is_VBZ
a_DT
context-dependent_JJ
apoptosis_NN
regulator_NN
._.

Our_PRP$
data_NNS
suggests_VBZ
that_IN
NF-kappaB_NN
may_MD
function_VB
as_IN
an_DT
antiapoptotic_JJ
factor_NN
in_IN
thymocytes_NNS
while_IN
functioning_VBG
as_IN
a_DT
proapoptotic_JJ
factor_NN
in_IN
mature_JJ
peripheral_JJ
T_NN
cells_NNS
._.

